Table 3.
Univariate and multivariate analysis of TyG index and LVEF < 40%.
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95%CI) | P value | OR (95%CI) | P value | |
| Age | 1.026 (1.004–1.049) | 0.020 | 1.012 (0.986–1.038) | 0.376 |
| Male | 1.371 (0.812–2.317) | 0.238 | ||
| SBP | 0.979 (0.968–0.991) | 0.001 | 0.983 (0.970–0.996) | 0.012 |
| DBP | 0.985 (0.967–1.003) | 0.104 | ||
| RHR | 1.020 (1.007–1.034) | 0.002 | 1.014 (1.000–1.029) | 0.055 |
| Ischemic time | 1.000 (0.999–1.003) | 0.734 | ||
| WBC | 1.014 (0.982–1.046) | 0.401 | ||
| Hb | 0.984 (0.973–0.995) | 0.005 | 0.992 (0.979–1.005) | 0.248 |
| TyG | 1.019 (0.695–1.494) | 0.924 | ||
| FBG | 1.084 (1.026–1.146) | 0.004 | 1.016 (0.937–1.102) | 0.702 |
| TG | 0.598 (0.410–0.873) | 0.008 | 0.652 (0.429–0.992) | 0.046 |
| BUN | 1.240 (1.144–1.343) | < 0.001 | 1.127 (0.996–1.275) | 0.058 |
| Creatinine | 1.018 (1.009–1.027) | < 0.001 | 1.002 (0.989–1.015) | 0.790 |
| LDL-C | 1.018 (0.744–1.392) | 0.911 | ||
| HDL-C | 1.765 (0.844–3.694) | 0.131 | ||
| TC | 1.050 (0.840–1.313) | 0.666 | ||
| UA | 1.002 (1.000–1.004) | 0.012 | 1.000 (0.999–1.002) | 0.651 |
| ApoA1 | 1.597 (0.541–4.715) | 0.396 | ||
| ApoB | 1.594 (0.608–4.181) | 0.343 | ||
| Lp(a) | 1.000 (0.999–1.001) | 0.954 | ||
| LAD as IRA | 2.677 (1.548–4.628) | < 0.001 | 2.452 (1.352–4.449) | 0.003 |
| Extent of coronary artery disease | ||||
| 1-vessel | 1 | – | 1 | – |
| 2-vessel | 1.94 (0.903–4.167) | 0.089 | 1.545 (0.686–3.481) | 0.294 |
| 3-vessel | 2.463 (1.209–5.018) | 0.013 | 1.266 (0.540–2.969) | 0.587 |
| Gensini score | 1.012 (1.007–1.017) | < 0.001 | 1.009 (1.003–1.016) | 0.003 |
| Hypertension | 0.814 (0.509–1.302) | 0.390 | ||
| Diabetes mellitus | 1.875 (1.147–3.063) | 0.012 | 0.919 (0.399–2.119) | 0.843 |
| Dyslipidemia | 1.617 (0.988–2.648) | 0.056 | ||
| Current Smoking | 1.326 (0.818–2.149) | 0.253 | ||
| Atrial fibrillation | 1.074 (0.317–3.640) | 0.909 | ||
| Family history of CAD | 1.339 (0.456–3.933) | 0.595 | ||
| Family history of cerebrovascular disease | 1.941 (1.121–3.361) | 0.018 | 1.378 (0.419–4.530) | 0.598 |
| Serum AP level Tertile | ||||
| I (low) | 1 | – | 1 | – |
| II (middle) | 1.529 (0.809–2.893) | 0.191 | 1.857 (0.920–3.750) | 0.084 |
| III (high) | 2.198 (1.197–4.036) | 0.011 | 2.598 (1.331–5.071) | 0.005 |
| Antiplatelets | 2.580 (0.930–7.153) | 0.069 | ||
| Beta-blocker | 0.770 (0.178–3.330) | 0.726 | ||
| Calcium inhibitor | 0.649 (0.349–1.207) | 0.172 | ||
| ACEI | – | 0.998 | ||
| Angiotensin II antagonist | 0.712 (0.214–2.367) | 0.580 | ||
| Diuretic | 2.263 (0.472–10.851) | 0.307 | ||
| Insulin | 1.421 (0.537–3.760) | 0.479 | ||
| Oral antidiabetic drug | 2.137 (1.173–3.892) | 0.013 | 1.779 (0.722–4.387) | 0.211 |
| Statin | 2.736 (0.981–7.632) | 0.055 | ||
| Atrial fibrillation | 1.074 (0.317–3.640) | 0.909 | ||
| Ventricular Tachycardia | 2.59 (0.529–12.692) | 0.240 | ||
| Heart arrest | 3.026 (0.600–15.258) | 0.180 | ||
| Pulmonary Infection | 2.189 (0.928–5.164) | 0.074 | ||
| Hydropericardium | 1.795 (0.207–15.562) | 0.596 | ||
TyG triglyceride-glucose, TG/HDL-C ratio triglyceride/high-density lipoprotein cholesterol ratio, STEMI ST-elevation myocardial infarction, WBC white blood cell, ACEI angiotensin converting enzyme inhibitor, Hb hemoglobin, CAD coronary artery disease, SBP systolic blood pressure, DBP diastolic blood pressure, RHR resting heart rate, LM left main coronary artery, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery, FBG fasting blood glucose, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, TC total cholesterol, UA uric acid, Lp(a) lipoprotein (a), ApoA1 apolipoprotein A1, ApoB apolipoprotein B, BUN blood urea nitrogen, LVEF left ventricular ejection fraction, AP alkaline phosphatase.